{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:43:50Z","timestamp":1754163830326,"version":"3.41.2"},"reference-count":50,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"DOI":"10.31744\/einstein_journal\/2025ao1154","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:07:26Z","timestamp":1753970846000},"source":"Crossref","is-referenced-by-count":0,"title":["Membrane transporter genes predict chemoradiotherapy response in patients with cervical cancer"],"prefix":"10.31744","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-4264","authenticated-orcid":false,"given":"Nat\u00e1lia Greg\u00f3rio","family":"Cust\u00f3dio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0238-5787","authenticated-orcid":false,"given":"F\u00e1bio Ribeiro","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-2355","authenticated-orcid":false,"suffix":"Neto","given":"Angelo Borges de","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5327-7751","authenticated-orcid":false,"given":"Brenda Martins","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4681-5451","authenticated-orcid":false,"given":"Laurence Rodrigues do","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4114-9183","authenticated-orcid":false,"given":"Telma Maria Rossi de Figueiredo","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7352-3089","authenticated-orcid":false,"given":"Matheus de Souza","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-2280","authenticated-orcid":false,"given":"Vasco Ariston de Carvalho","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6181-9410","authenticated-orcid":false,"given":"Let\u00edcia da Concei\u00e7\u00e3o","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8839-3491","authenticated-orcid":false,"given":"Paulo Guilherme de Oliveira","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8204-6712","authenticated-orcid":false,"given":"Wander de Jesus","family":"Jeremias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"issue":"1","key":"key20250731140721_B1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","unstructured":"1 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"key20250731140721_B2","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1038\/s41467-022-33544-x","article-title":"Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance","volume":"13","author":"Chakravarthy","year":"2022","unstructured":"2 Chakravarthy A, Reddin I, Henderson S, Dong C, Kirkwood N, Jeyakumar M, et al. Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance. Nat Commun. 2022;13(1):5818.","journal-title":"Nat Commun"},{"key":"key20250731140721_B3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3332\/ecancer.2019.975","article-title":"Elimination of cervical cancer: challenges for developing countries","volume":"13","author":"Beddoe","year":"2019;","unstructured":"3 Beddoe AM. Elimination of cervical cancer: challenges for developing countries. Ecancermedicalscience. 2019;13:975.","journal-title":"Ecancermedicalscience"},{"issue":"10167","key":"key20250731140721_B4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","unstructured":"4 Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019; 393(10167):169-82.","journal-title":"Lancet"},{"issue":"6","key":"key20250731140721_B5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.21147\/j.issn.1000-9604.2020.06.05","article-title":"Cervical cancer: Epidemiology, risk factors and screening","volume":"32","author":"Zhang","year":"2020","unstructured":"5 Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2020;32(6):720-8.","journal-title":"Chin J Cancer Res"},{"key":"key20250731140721_B6","volume-title":"Key statistics for cervical cancer","author":"American Cancer Society. (Internet)","year":"2022","unstructured":"6 American Cancer Society. (Internet). Key statistics for cervical cancer. EUA: ASC; 2022 [cited 2022 Nov 18]. Available from: https:\/\/www.cancer.org\/cancer\/types\/cervical-cancer\/about\/key-statistics.html"},{"key":"key20250731140721_B7","first-page":"72","article-title":"ESMO Guidelines Committee","volume":"28","author":"Marth","year":"2017","unstructured":"7 Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N; ESMO Guidelines Committee. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28 suppl_4:iv72-83.","journal-title":"Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"},{"key":"key20250731140721_B8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/B978-0-12-824299-5.00010-1","article-title":"Chapter 8 - Overcoming drug resistance in cervical cancer: Chemosensitizing agents and targeted therapies","volume":"17","author":"Anum Jalil","year":"2021","unstructured":"8 Anum Jalil A, Wert J, Farooq A, Ahmad S. Chapter 8 - Overcoming drug resistance in cervical cancer: Chemosensitizing agents and targeted therapies. Over Drug Res Gynecol Cancers. 2021;17:195-205.","journal-title":"Over Drug Res Gynecol Cancers"},{"issue":"12","key":"key20250731140721_B9","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1007\/s11010-021-04249-4","article-title":"Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA","volume":"476","author":"Mitra","year":"2021","unstructured":"9 Mitra T, Elangovan S. Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA. Mol Cell Biochem. 2021;476(12):4363-85.","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"key20250731140721_B10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/cancers12061624","article-title":"Exploring the therapeutic potential of membrane transport proteins: focus on cancer and Chemoresistance","volume":"12","author":"Almasi","year":"2020","unstructured":"10 Almasi S, El Hiani Y. Exploring the therapeutic potential of membrane transport proteins: focus on cancer and Chemoresistance. Cancers (Basel). 2020;12(6):1624.","journal-title":"Cancers (Basel)"},{"issue":"35","key":"key20250731140721_B11","doi-asserted-by":"crossref","first-page":"59950","DOI":"10.18632\/oncotarget.19048","article-title":"The molecular mechanisms of chemoresistance in cancers","volume":"8","author":"Zheng","year":"2017","unstructured":"11 Zheng HC. The molecular mechanisms of chemoresistance in cancers. Oncotarget. 2017;8(35):59950-64.","journal-title":"Oncotarget"},{"issue":"4","key":"key20250731140721_B12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/17512433.2019.1581605","article-title":"Unraveling \u2018The Cancer Genome Atlas\u2019 information on the role of SLC transporters in anticancer drug uptake","volume":"12","author":"Al-Abdulla","year":"2019","unstructured":"12 Al-Abdulla R, Perez-Silva L, Abete L, Romero MR, Briz O, Marin JJ. Unraveling \u2018The Cancer Genome Atlas\u2019 information on the role of SLC transporters in anticancer drug uptake. Expert Rev Clin Pharmacol. 2019;12(4):329-41.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"key20250731140721_B13","doi-asserted-by":"crossref","first-page":"654454","DOI":"10.3389\/fpubh.2021.654454","article-title":"Prediction models for prognosis of cervical cancer: systematic review and critical appraisal","volume":"9","author":"He","year":"2021;","unstructured":"13 He B, Chen W, Liu L, Hou Z, Zhu H, Cheng H, et al. Prediction models for prognosis of cervical cancer: systematic review and critical appraisal. Front Public Health. 2021;9:654454.","journal-title":"Front Public Health"},{"issue":"3","key":"key20250731140721_B14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10555-020-09879-6","article-title":"Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis","volume":"39","author":"Sutherland","year":"2020","unstructured":"14 Sutherland R, Meeson A, Lowes S. Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis. Cancer Metastasis Rev. 2020;39(3):919-32.","journal-title":"Cancer Metastasis Rev"},{"key":"key20250731140721_B15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.omto.2021.08.015","article-title":"Defueling the cancer: ATP synthase as an emerging target in cancer therapy","volume":"23","author":"Wang","year":"2021","unstructured":"15 Wang T, Ma F, Qian HL. Defueling the cancer: ATP synthase as an emerging target in cancer therapy. Mol Ther Oncolytics. 2021;23:82-95.","journal-title":"Mol Ther Oncolytics"},{"issue":"3","key":"key20250731140721_B16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tips.2005.01.002","article-title":"Mechanisms of platinum drug resistance","volume":"26","author":"Ohmichi","year":"2005","unstructured":"16 Ohmichi M, Hayakawa J, Tasaka K, Kurachi H, Murata Y. Mechanisms of platinum drug resistance. Trends Pharmacol Sci. 2005;26(3):113-6.","journal-title":"Trends Pharmacol Sci"},{"key":"key20250731140721_B17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semcancer.2021.05.023","article-title":"Interference between copper transport systems and platinum drugs","volume":"76","author":"Arnesano","year":"2021","unstructured":"17 Arnesano F, Natile G. Interference between copper transport systems and platinum drugs. Semin Cancer Biol. 2021;76:173-88.","journal-title":"Semin Cancer Biol"},{"key":"key20250731140721_B18","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.csbj.2021.07.003","article-title":"Machine learning in the prediction of cancer therapy","volume":"19","author":"Rafique","year":"2021","unstructured":"18 Rafique R, Islam SM, Kazi JU. Machine learning in the prediction of cancer therapy. Comput Struct Biotechnol J. 2021;19:4003-17.","journal-title":"Comput Struct Biotechnol J"},{"key":"key20250731140721_B19","doi-asserted-by":"crossref","first-page":"639339","DOI":"10.3389\/fonc.2021.639339","article-title":"Cervical cancer stem-like cell transcriptome profiles predict response to chemoradiotherapy","volume":"11","author":"Zuccherato","year":"2021;","unstructured":"19 Zuccherato LW, Machado CM, Magalh\u00e3es WC, Martins PR, Campos LS, Braga LC, et al. Cervical cancer stem-like cell transcriptome profiles predict response to chemoradiotherapy. Front Oncol. 2021;11:639339.","journal-title":"Front Oncol"},{"issue":"1","key":"key20250731140721_B20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"CUTADAPT removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","unstructured":"20 Martin M. CUTADAPT removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):10.","journal-title":"EMBnet J"},{"issue":"1","key":"key20250731140721_B21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","unstructured":"21 Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15-21.","journal-title":"Bioinformatics"},{"issue":"12","key":"key20250731140721_B22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","unstructured":"22 Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"journal-title":"enrichplot: Visualization of Functional Enrichment Result","author":"Yu","key":"key20250731140721_B23","unstructured":"23 Yu G. enrichplot: Visualization of Functional Enrichment Result. R package version 1.18.3 [cited 2024 May 22] Available from: https:\/\/yulab-smu.top\/biomedical-knowledge-mining-book\/enrichplot.html"},{"issue":"17","key":"key20250731140721_B24","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/bioinformatics\/btt350","article-title":"Data-based filtering for replicated high-throughput transcriptome sequencing experiments","volume":"29","author":"Rau","year":"2013","unstructured":"24 Rau A, Gallopin M, Celeux G, Jaffr\u00e9zic F. Data-based filtering for replicated high-throughput transcriptome sequencing experiments. Bioinformatics. 2013;29(17):2146-52.","journal-title":"Bioinformatics"},{"issue":"3","key":"key20250731140721_B25","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","unstructured":"25 Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141.","journal-title":"Innovation (Camb)"},{"issue":"5","key":"key20250731140721_B26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","unstructured":"26 Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284-7.","journal-title":"OMICS"},{"key":"key20250731140721_B27","first-page":"403","volume-title":"Morgan Kaufmann","author":"Witten","unstructured":"27 Witten IH, Frank E, Hall MA. Introduction to weka, In: Data Mining: Practical Machine Learning Tools and Techniques. Morgan Kaufmann; 3rd ed. pp. 403-6.","edition":"3rd ed"},{"key":"key20250731140721_B28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","article-title":"Cisplatin resistance and opportunities for precision medicine","volume":"106","author":"Amable","year":"2016","unstructured":"28 Amable L. Cisplatin resistance and opportunities for precision medicine. Pharmacol Res. 2016;106:27-36.","journal-title":"Pharmacol Res"},{"issue":"11-12","key":"key20250731140721_B29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00439-019-02081-x","article-title":"The genetic landscape of the human solute carrier (SLC) transporter superfamily","volume":"138","author":"Schaller","year":"2019","unstructured":"29 Schaller L, Lauschke VM. The genetic landscape of the human solute carrier (SLC) transporter superfamily. Hum Genet. 2019;138(11-12):1359-77.","journal-title":"Hum Genet"},{"key":"key20250731140721_B30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/B978-044452763-9\/50071-8","article-title":"67 - anti-atp synthase \u03b2-chain autoantibodies","author":"Musante","year":"2007","unstructured":"30 Musante L, Candiano G, Bruschi M, Santucci L, Ghiggeri GM. 67 - anti-atp synthase \u03b2-chain autoantibodies. Autoantibodies. 2007;547-52.","journal-title":"Autoantibodies"},{"issue":"10","key":"key20250731140721_B31","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0021-9258(18)96640-8","article-title":"Partial resolution of the enzymes catalyzing oxidative phosphorylation. 8. Properties of a factor conferring oligomycin sensitivity on mitochondrial adenosine triphosphatase","volume":"241","author":"Kagawa","year":"1966","unstructured":"31 Kagawa Y, Racker E. Partial resolution of the enzymes catalyzing oxidative phosphorylation. 8. Properties of a factor conferring oligomycin sensitivity on mitochondrial adenosine triphosphatase. J Biol Chem. 1966;241(10):2461-6.","journal-title":"J Biol Chem"},{"issue":"11","key":"key20250731140721_B32","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1517\/14728222.12.11.1403","article-title":"Na+\/K+-ATPase \u03b1 subunits as new targets in anticancer therapy","volume":"12","author":"Mijatovic","year":"2008","unstructured":"32 Mijatovic T, Ingrassia L, Facchini V, Kiss R. Na+\/K+-ATPase \u03b1 subunits as new targets in anticancer therapy. Expert Opin Ther Targets. 2008;12(11): 1403-17.","journal-title":"Expert Opin Ther Targets"},{"key":"key20250731140721_B33","first-page":"1141","article-title":"Drug transporters in drug disposition, effects and toxicity [Preprint]","author":"Liu","year":"2019","unstructured":"33 Liu X. Drug transporters in drug disposition, effects and toxicity [Preprint]. Adv Exp Med Biol. 2019;1141.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"key20250731140721_B34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1091\/mbc.12.2.279","article-title":"Na,K-ATPase \u03b2-subunit is required for epithelial polarization, suppression of invasion, and cell motility","volume":"12","author":"Rajasekaran","year":"2001","unstructured":"34 Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball WJ Jr, Bander NH, et al. Na,K-ATPase \u03b2-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell. 2001;12(2):279-95.","journal-title":"Mol Biol Cell"},{"issue":"48","key":"key20250731140721_B35","doi-asserted-by":"crossref","first-page":"84285","DOI":"10.18632\/oncotarget.20894","article-title":"Expression of the \u03b23 subunit of Na+\/K+-ATPase is increased in gastric cancer and regulates gastric cancer cell progression and prognosis via the PI3\/AKT pathway","volume":"8","author":"Li","year":"2017","unstructured":"35 Li L, Feng R, Xu Q, Zhang F, Liu T, Cao J, et al. Expression of the \u03b23 subunit of Na+\/K+-ATPase is increased in gastric cancer and regulates gastric cancer cell progression and prognosis via the PI3\/AKT pathway. Oncotarget. 2017;8(48):84285-99.","journal-title":"Oncotarget"},{"issue":"4","key":"key20250731140721_B36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41589-020-0483-3","article-title":"A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs","volume":"16","author":"Girardi","year":"2020","unstructured":"36 Girardi E, C\u00e9sar-Razquin A, Lindinger S, Papakostas K, Konecka J, Hemmerich J, et al. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs. Nat Chem Biol. 2020;16(4):469-78.","journal-title":"Nat Chem Biol"},{"issue":"8","key":"key20250731140721_B37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138920011798357060","article-title":"Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments","volume":"12","author":"Cutler","year":"2011","unstructured":"37 Cutler MJ, Choo EF. Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments. Curr Drug Metab. 2011;12(8):793-807.","journal-title":"Curr Drug Metab"},{"issue":"2-3","key":"key20250731140721_B38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mam.2012.05.005","article-title":"The mitochondrial transporter family SLC25: identification, properties and physiopathology","volume":"34","author":"Palmieri","year":"2013","unstructured":"38 Palmieri F. The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Aspects Med. 2013;34(2-3):465-84.","journal-title":"Mol Aspects Med"},{"issue":"2","key":"key20250731140721_B39","doi-asserted-by":"crossref","first-page":"150108","DOI":"10.1098\/rsob.150108","article-title":"Changes in the expression of the human adenine nucleotide translocase isoforms condition cellular metabolic\/proliferative status","volume":"6","author":"Gavald\u00e0-Navarro","year":"2016","unstructured":"39 Gavald\u00e0-Navarro A, Mampel T, Vi\u00f1as O. Changes in the expression of the human adenine nucleotide translocase isoforms condition cellular metabolic\/proliferative status. Open Biol. 2016;6(2):150108.","journal-title":"Open Biol"},{"issue":"3","key":"key20250731140721_B40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41419-022-04692-1","article-title":"An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis","volume":"13","author":"Chen","year":"2022","unstructured":"40 Chen YJ, Hong WF, Liu ML, Guo X, Yu YY, Cui YH, et al. An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis. Cell Death Dis. 2022;13(3):237.","journal-title":"Cell Death Dis"},{"issue":"2","key":"key20250731140721_B41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10545-011-9382-9","article-title":"Mitochondrial ATP synthase: architecture, function and pathology","volume":"35","author":"Jonckheere","year":"2012","unstructured":"41 Jonckheere AI, Smeitink JA, Rodenburg RJ. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis. 2012;35(2):211-25.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"key20250731140721_B42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrm729","article-title":"The vacuolar (H+)-ATPases\u2014nature's most versatile proton pumps","volume":"3","author":"Nishi","year":"2002","unstructured":"42 Nishi T, Forgac M. The vacuolar (H+)-ATPases\u2014nature's most versatile proton pumps. Nat Rev Mol Cell Biol. 2002;3(2):94-103.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"key20250731140721_B43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0006-2952(03)00468-4","article-title":"Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents","volume":"66","author":"Raghunand","year":"2003","unstructured":"43 Raghunand N, Mahoney BP, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol. 2003;66(7):1219-29.","journal-title":"Biochem Pharmacol"},{"issue":"2-3","key":"key20250731140721_B44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mam.2012.12.009","article-title":"The ABCs of membrane transporters in health and disease (SLC series): introduction","volume":"34","author":"Hediger","year":"2013","unstructured":"44 Hediger MA, Cl\u00e9men\u00e7on B, Burrier RE, Bruford EA. The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol Aspects Med. 2013;34(2-3):95-107.","journal-title":"Mol Aspects Med"},{"issue":"2-3","key":"key20250731140721_B45","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.mam.2012.11.004","article-title":"Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K","volume":"34","author":"Motohashi","year":"2013","unstructured":"45 Motohashi H, Inui K. Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K. Mol Aspects Med. 2013;34(2-3):661-8.","journal-title":"Mol Aspects Med"},{"key":"key20250731140721_B46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2019.10.004","article-title":"The ABC subfamily A transporters: multifaceted players with incipient potentialities in cancer","volume":"60","author":"Pasello","year":"2020","unstructured":"46 Pasello M, Giudice AM, Scotlandi K. The ABC subfamily A transporters: multifaceted players with incipient potentialities in cancer. Semin Cancer Biol. 2020;60:57-71.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"key20250731140721_B47","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.18632\/aging.203933","article-title":"Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer","volume":"14","author":"Chu","year":"2022","unstructured":"47 Chu PY, Tzeng YT, Tsui KH, Chu CY, Li CJ. Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer. Aging (Albany NY). 2022;14(5):2252-67.","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"key20250731140721_B48","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138920011798357060","article-title":"Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments","volume":"12","author":"Cutler","year":"2011","unstructured":"48 Cutler MJ, Choo EF. Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments. Curr Drug Metab. 2011;12(8):793-807.","journal-title":"Curr Drug Metab"},{"issue":"6","key":"key20250731140721_B49","first-page":"6605","article-title":"A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma","volume":"18","author":"Wang","year":"2019","unstructured":"49 Wang S, Chai K, Chen J. A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma. Oncol Lett. 2019;18(6):6605-13.","journal-title":"Oncol Lett"},{"issue":"1","key":"key20250731140721_B50","first-page":"87","article-title":"Identification of novel diagnostic and prognostic biomarkers for hepatocellular carcinoma","volume":"43","author":"Wang","year":"2020","unstructured":"50 Wang F, Dong J, Zhang Y, Yue S, Guo H, Liang P, et al. Identification of novel diagnostic and prognostic biomarkers for hepatocellular carcinoma. Oncol Rep. 2020;43(1):87-98.","journal-title":"Oncol Rep"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:07:33Z","timestamp":1753970853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/membrane-transporter-genes-predict-chemoradiotherapy-response-in-patients-with-cervical-cancer\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":50,"alternative-id":["10.31744\/einstein_journal\/2025AO1154"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2025ao1154","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"type":"print","value":"1679-4508"},{"type":"electronic","value":"2317-6385"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"eAO1154"}}